Document Detail


Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive.
MedLine Citation:
PMID:  21663381     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
ABSTRACT Hallucinations, delusions, and compulsive behaviors are frequent iatrogenic complications of the treatment of motor dysfunction in Parkinson's disease (PD). Although these have been studied, and the phenomenology described, there are few detailed descriptions of the various psychiatric problems our treated PD patients live with that allow physicians who do not have a great deal of experience with PD patients to appreciate the extent of their altered lives. This report is a compilation of vignettes describing these behavioral problems that the treating neurologist or psychiatrist attributed to the medications used for treating PD.
Authors:
Joseph H Friedman; P Agarwal; R Alcalay; K J Black; K L Chou; L Cote; P Dayalu; S Frank; J Hartlein; R A Hauser; A E Lang; L Marsh; F Marshall; C Moskowitz; B Ravina; D Riley; J Sanchez-Ramos; D K Simon; T Simuni; J Sutton; P Tuite; D Weintraub; T Zesiewicz
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-10
Journal Detail:
Title:  The International journal of neuroscience     Volume:  -     ISSN:  1563-5279     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-6-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0270707     Medline TA:  Int J Neurosci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Neurology, Alpert School of Medicine, Brown University, Providence, Rhode Island, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association Between the MTHFR Gene and Alzheimer's Disease: A Meta-Analysis.
Next Document:  Screening for Well-Characterized Paraneoplastic Antineuronal Antibodies in Multiple Sclerosis.